Skip to main content
. 2022 Mar 11;6(6):1651–1660. doi: 10.1182/bloodadvances.2021006415

Figure 4.

Figure 4.

ctDNA MMPM at baseline in patients with or without CR at EOT; P = .049 for difference between patients with CR and no CR by Wilcoxon test.